The Mitotane Tablets, cataloged under National Stock Number 6505-01-186-8147, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hra Pharma America, Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 3 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-186-8147 |
| Primary Part Number | NDC76336-0080-60 |
| Item Name | Mitotane Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hra Pharma America, Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 500.000 MILLIGRAMS MITOTANE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC76336-0080-60 PRIMARY | Hra Pharma America, Inc. (USA) |
| Reference | Meaning |
|---|---|
| LYSODREN TABLETS | 5/1 Secondary reference Mead Johnson & Company, Llc |
| LYSODREN | 5/1 Secondary reference Mead Johnson & Company, Llc |
| NDC00015-3080-60 | 5/9 Secondary reference Bristol-Myers Squibb Company Dba Bristol-Myers Squibb |
NSN 6505-01-186-8147 is a Mitotane Tablets, manufactured by Hra Pharma America, Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-186-8147 has 1 manufacturer part number on file: NDC76336-0080-60 (Hra Pharma America, Inc.).
Key specifications for NDC76336-0080-60: Primary Container Content Quantity: 100.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: MITOTANE TABLETS USP 500MG 100S BT. 4 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.